Pet Dewormers Market Size To Reach $5.32 Billion By 2033

Pet Dewormers Market Growth & Trends

The global pet dewormers market size is expected to reach USD 5.32 billion by 2033, registering a CAGR of 9.2% from 2026 to 2033, according to a new report by Grand View Research, Inc. Some key factors driving the market growth are awareness and education efforts regarding parasitic worms, the growing importance of parasite control in pets, the emergence of new parasitic worms, and growing R&D initiatives. Studies show a high prevalence of parasites in pets across the U.S., EU, and UK, with parasitic worms and vector-borne diseases (VBDs) like Lyme disease and heartworm spreading to new areas. Parasites such as ticks, fleas, and leishmania can transmit diseases to humans, correlating with pet infection rates. For instance, leishmaniosis has significant fatality rates in Brazil, and flea infestations can persist for months without intervention.

Furthermore, low compliance rates among pet owners globally highlight untapped market potential for deworming products. In the Netherlands, UK, and Portugal, only 5-16% of pets follow recommended deworming practices, signaling a need for increased education and product adoption. Regional veterinary councils (CAPC, ESCCAP, TROCCAP) play a crucial role in setting guidelines and promoting effective parasite control.

The growing prevalence of parasitic diseases and, subsequently, the rise in the importance of parasitic control in pets is expected to drive market growth rapidly. Parasites such as fleas, ticks, mites, and worms pose lifelong risks to pets, causing discomfort, disease, and potential transmission of zoonotic illnesses to humans, especially vulnerable populations like children, the elderly, or immunocompromised individuals. Global factors like rising pet populations, climate change, and increased mobility are expanding parasite prevalence and geographic spread, necessitating effective control measures. For instance, according to the May 2024 article by Animal Friend Life reported that weather conditions in Australia have led to a rise in roundworm infections among dogs as well as humans. Spread of parasitic worms like Toxocara roundworms has affected around two million Australians. Many pet owners, i.e., around 25%, have admitted to never deworming their dogs. Experts have recommended regular deworming, prompt disposal of pet feces, and avoiding raw meat diets for pets to tackle this situation in its early stages.

 Request a free sample copy or view report summary: Pet Dewormers Market Report

Pet Dewormers Market Report Highlights

• By pet, the dogs segment held the largest share of 47.49% in the market in 2025. Cats segment is anticipated to register the fastest CAGR from 2026 to 2033.

• By type, the prescription segment dominated the market with a revenue share of 64.23% in 2025 and is anticipated to grow at the fastest CAGR of 9.4% over the forecast period.

• By route of administration, the oral segment held the largest market share in 2025. The topical segment is experiencing a significant growth in the pet dewormers market.

• By dosage form, the solid segment dominated the market with a revenue share of 51.69% in 2025. The others segment is anticipated to grow at the fastest CAGR of 9.7% from 2026 to 2033.

• By distribution channel, the veterinary hospitals/clinics segment held the highest share of the market in 2025. E-commerce segment is estimated to grow at the fastest CAGR during the forecast period.

• North America pet dewormers market held the largest revenue share of 35.19% in 2025. U.S. pet dewormers market dominated with largest revenue share in 2025.

Global Pet Dewormers Market Segmentation

Grand View Research has segmented global pet dewormers market report based on pet, route of administration, dosage form, type, distribution channel, and region:

Pet Dewormers Pet Outlook (Revenue, USD Million, 2021 - 2033)

• Dogs

• Cats

• Horses

• Other Pets

Pet Dewormers Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)

• Oral

• Injectable

• Topical  

Pet Dewormers Dosage Form Outlook (Revenue, USD Million, 2021 - 2033)

• Solid

• Liquid

• Others

Pet Dewormers Type Outlook (Revenue, USD Million, 2021 - 2033)

• OTC

• Prescription

Pet Dewormers Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Veterinary Hospitals/Clinics

• Retail/Pet Stores

• E-commerce

Pet Dewormers Region Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Spain

  • Germany

  • Portugal

  • Romania

  • Slovakia

  • Czech Republic

  • Hungary

  • Poland

  • Italy

  • Ireland

  • UK

  • France

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • UAE

  • Saudi Arabia

  • Kuwait

List of Key Players of Pet Dewormers Market

• Zoetis

• Boehringer Ingelheim

• Merck & Co., Inc.

• Elanco Animal Health

• Dechra Pharmaceuticals PLC

• Virbac

• Vetoquinol

• Hester Biosciences Limited

• Ceva Santé Animale

• Intas Pharmaceuticals Ltd.